Crispr Therapeutics AG (CRSP)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 5.57B
P/E Ratio
0.00
Revenue (TTM)
$ 38.05M
Volume
0
52W High
$ 71.13
52W Low
$ 30.04
Dividend Yield
0.00%
Beta
1.81
Technicals
50-Day MA
57.04
200-Day MA
45.4805
52 Week High
71.13
52 Week Low
30.04
About CRSP
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISP.
Employees
393
Headquarters
Zug, Switzerland
CEO
Dr. Samarth Kulkarni Ph.D.